CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.20 USD
-0.01 (-0.83%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $1.21 +0.01 (0.83%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for CoDiagnostics, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7 | 34 | 98 | 75 | 0 |
Cost Of Goods | 4 | 5 | 12 | 17 | 0 |
Gross Profit | 3 | 29 | 86 | 58 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 45 | 56 | 40 | 16 | 6 |
Income After Depreciation & Amortization | -43 | -27 | 46 | 42 | -6 |
Non-Operating Income | 5 | 8 | 0 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -38 | -19 | 46 | 43 | -6 |
Income Taxes | -3 | -5 | 9 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -35 | -14 | 37 | 42 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -35 | -14 | 37 | 42 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -41 | -10 | 46 | 42 | -6 |
Depreciation & Amortization (Cash Flow) | 1 | 17 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -43 | -27 | 46 | 42 | -6 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.35 | 31.48 | 29.90 | 28.00 | 16.76 |
Diluted EPS Before Non-Recurring Items | -1.20 | -0.26 | 1.23 | 1.52 | -0.36 |
Diluted Net EPS (GAAP) | -1.20 | -0.45 | 1.23 | 1.52 | -0.36 |
Fiscal Year end for CoDiagnostics, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2.66 | 0.47 | 3.56 | 2.46 | 0.20 |
Cost Of Goods | 0.21 | 0.23 | 2.97 | 0.26 | 0.46 |
Gross Profit | 2.44 | 0.23 | 0.59 | 2.20 | -0.26 |
SG&A, R&D, and Dept/Amort Expenses | 10.12 | 10.49 | 12.41 | 11.14 | 11.74 |
Income After SG&A, R&D, and Dept/Amort Expenses | -7.68 | -10.26 | -11.82 | -8.94 | -12.00 |
Non-Operating Income | 0.10 | 0.97 | 0.98 | 0.84 | 0.84 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -7.58 | -9.29 | -10.84 | -8.10 | -11.16 |
Income Taxes | 0.02 | 0.02 | 3.83 | -2.11 | -2.24 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.60 | -9.31 | -14.68 | -5.98 | -8.92 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -7.60 | -9.31 | -14.68 | -5.98 | -8.92 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 30.13 | 29.84 | 29.35 | 29.36 | 29.09 |
Diluted EPS Before Non-Recurring Items | -0.25 | -0.31 | -0.50 | -0.20 | -0.31 |
Diluted Net EPS (GAAP) | -0.25 | -0.31 | -0.49 | -0.20 | -0.31 |